Private MD News - Prostate

Home | News | Prostate

View Articles by Date

Year: 2013 2012 2011 2010 2009

Month: JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

A new study published in the Journal of the American Medical Association reports that there was a slight decrease in the number of cases of cancer among men who took vitamins during a decade-long trial, BBC News reported.

The research, which was conducted at Brigham and Women's Hospital and Harvard Medical School, looked at 15,000 men who were over 50 years old for more than ten years. The men were divided up into two groups: One received a multivitamin every day, while the other group took a sugar pill daily. The results showed that there were 17 cases of cancer for every 1,000 men who took the vitamins and 18 cases of cancer for every 1,000 men who took the placebo.

The news source noted that many experts recommend a diet rich in fruits and vegetables in order to receive the proper amount of nutrients.

"Now we know that taking a daily multivitamin, in addition to addressing vitamin and mineral deficiencies, may also be considered in the prevention of cancer in middle-aged and older men," one of the research authors, Howard Sesso, Sc.D., M.P.H. told BBC News.

You can find out if you're deficient in a certain vitamin by taking a blood test. According to the National Institutes of Health (NIH), individuals who experience numbness or tingling in the extremities may want to get tested for levels vitamin B12, because these symptoms can be caused by a deficiency in the nutrient.

HealthDay News has reported that a new study may indicate that consuming more flavonoid compounds can help curb the threat of aggressive prostate cancer.... Full Story

According to new research, which was funded by Cancer Research UK and published in the journal Nature Cell Biology, testing for a protein that may be able to indicate how severe a person's prostate cancer will be.

The study showed that the protein is responsible for keeping cells tightly connected and preserving the tissue's structure, which helps prevent cancerous cells from spreading. Not only does this indicate how lethal the prostate cancer is, but it can also be a predictor for its recurrence.

"Our findings indicate that the loss of β2-syntrophin at cell-to-cell connections in the prostate is an indicator of prostate cancer progression and patients with reduced levels of this protein at these cell-to-cell connections are more likely to have a recurrence of their cancer after treatment," said research author Natalie Mack, M.D.

The authors also noted that further research on the protein should be conducted so healthcare providers can tell the risk level of patients who are diagnosed with prostate cancer, so they can be treated effectively.

Prostate cancer risk factors... Full Story